Y-mabs Therapeutics share price today
(YMAB)
Y-mabs Therapeutics share price is $7.84 & ₹672.75 as on 7 Jan 2025, 2.30 'hrs' IST
$7.84
Market is closed - opens 8 PM, 07 Jan 2025
View live Y-mabs Therapeutics share price in Dollar and Rupees. Guide to invest in Y-mabs Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Y-mabs Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Y-mabs Therapeutics share price movements
- Today's Low: $7.81Today's High: $8.34
0.38%
Downside
Day's Volatility :6.35%
Upside
6.0%
- 52 Weeks Low: $6.5352 Weeks High: $20.90
16.71%
Downside
52 Weeks Volatility :68.76%
Upside
62.49%
Y-mabs Therapeutics Returns
Y-mabs Therapeutics Key Statistics
in dollars & INR
How to invest in Y-mabs Therapeutics from India?
It is very easy for Indian residents to invest directly in Y-mabs Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Y-mabs Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Y-mabs Therapeutics or YMAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Y-mabs Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Y-mabs Therapeutics shares which would translate to 0.109 fractional shares of Y-mabs Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Y-mabs Therapeutics, in just a few clicks!
Returns in Y-mabs Therapeutics for Indian investors in Rupees
Investment Value
₹1,00,000
Y-mabs Therapeutics investment value today
Current value as on today
₹1,04,124
Returns
₹4,124
(+4.12%)
Returns from Y-mabs Therapeutics Stock
₹901 (+0.90%)
Dollar Returns
₹3,223 (+3.22%)
Indian investors sentiment towards Y-mabs Therapeutics
Global Institutional Holdings in Y-mabs Therapeutics
Paradigm Biocapital Advisors LP
9.12%
BlackRock Inc
6.56%
Sofinnova Ventures
4.90%
Vanguard Group Inc
4.54%
Polar Capital Holdings PLC
4.09%
Cormorant Asset Management, LLC
3.24%
Analyst Recommendation on Y-mabs Therapeutics
Buy
76%Buy
15%Hold
7%Sell
Based on 13 Wall street analysts offering stock ratings for Y-mabs Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Y-mabs Therapeutics
What analysts predicted
Upside of 163.22%
Current:
$7.84
Target:
$20.64
Insights on Y-mabs Therapeutics
Price Movement
In the last 1 month, YMAB stock has moved down by -22.5%Decreasing Revenue
Revenue is down for the last 2 quarters, 22.79M → 18.46M (in $), with an average decrease of 19.0% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -9.24M → -6.99M (in $), with an average increase of 32.2% per quarterYMAB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 9.9%YMAB vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 100.4%Price to Sales
ForYMAB every $1 of sales, investors are willing to pay $4.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.
Y-mabs Therapeutics Technicals Summary
Sell
Neutral
Buy
Y-mabs Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Y-mabs Therapeutics Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -20.37% | -27.51% | 5.15% | -42.99% | -74.24% |
 | -8.86% | -31.87% | -20.46% | 15.59% | 87.28% |
 | -4.16% | 43.82% | 3.49% | -49.66% | 167.6% |
 | -8.45% | -8.03% | 19.03% | 56.02% | 98.44% |
 | -14.11% | -16.23% | -2.87% | 81.78% | 76.8% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.59 | -0.25 | -0.12 | NA | 2.07 |
| 17.61 | 17.61 | 1.06 | 45.07 | 0.17 | 0.07 | NA | 272.04 |
| 160.8 | NA | 0.04 | -3.11 | -0.02 | -0.01 | NA | 79.73 |
| NA | NA | -0.49 | -0.19 | -15.01 | -0.03 | NA | 0.25 |
| 32.84 | NA | 1.06 | 0.51 | -0.03 | 0.12 | NA | 60.65 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $350.7M | -74.24% | NA | -28.22% |
| Buy | $78.3B | 87.28% | 17.61 | 33.61% |
| Buy | $27.3B | 167.6% | 160.8 | -15.36% |
| Buy | $30.4B | 98.44% | NA | -15.86% |
| Buy | $103.7B | 76.8% | 32.84 | -4.51% |
About Y-mabs Therapeutics
Management People of Y-mabs Therapeutics
Important FAQs about investing in Y-mabs Therapeutics from India :
What is Y-mabs Therapeutics share price today?
Y-mabs Therapeutics share price today stands at $7.84, Open: $8.22 ; Previous Close: $8.17 ; High: $8.34 ; Low: $7.81 ; 52 Week High: $20.90 ; 52 Week Low: $6.53. The stock opens at $8.22, after a previous close of $8.17. The stock reached a daily high of $8.34 and a low of $7.81, with a 52-week high of $20.90 and a 52-week low of $6.53.
Can Indians buy Y-mabs Therapeutics shares?
Yes, Indians can invest in the Y-mabs Therapeutics (YMAB) from India.
With INDmoney, you can buy Y-mabs Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Y-mabs Therapeutics at zero transaction cost.
How can I buy Y-mabs Therapeutics shares from India?
It is very easy to buy Y-mabs Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Y-mabs Therapeutics be purchased?
Yes, you can buy fractional shares of Y-mabs Therapeutics with INDmoney app.
What are the documents required to start investing in Y-mabs Therapeutics stocks?
To start investing in Y-mabs Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Y-mabs Therapeutics
Today’s highest price of Y-mabs Therapeutics (YMAB) is $8.34.
Today’s lowest price of Y-mabs Therapeutics (YMAB) is $7.81.
What is today's market capitalisation of Y-mabs Therapeutics
What is the 52 Week High and Low Range of Y-mabs Therapeutics
52 Week High
$20.90
52 Week Low
$6.53
What are the historical returns of Y-mabs Therapeutics?
1 Month Returns
-20.37%
3 Months Returns
-27.51%
1 Year Returns
5.15%
5 Years Returns
-74.24%
